๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Guangzhou
Clinical trial register · China

Clinical Trials in Guangzhou

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Guangzhou 451 Beijing 25 Shenzhen 23 Zhongshan 17 Nanning 17
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University451 Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University181 Nanfang Hospital, Southern Medical University138 AstraZeneca133 Guangdong Provincial People's Hospital81 Clear sponsor filter
Site location
Guangzhou451 Beijing25 Shenzhen23 Zhongshan17 Nanning17
All 55 locations
Target enrolment
to
451 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Active, closed
Radiotherapy Plus Nimotuzumab or Cisplatin in Nasopharyngeal Carcinoma
NCT04456322Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3
381
Guangzhou
2020-08-17
Recruiting
Toripalimab Plus Concurrent Chemo-radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma
NCT04453813Nasopharyngeal Carcinoma, Chemotherapy, Radiotherapy, PD-1 Treatment
Sun Yat-sen University
Phase 3
226
Guangzhou, Shaoguan, Zhongshan, Zhuhai, Wuzhou
2020-07-03
Recruiting
Plasma Radiofrequency Ablation at Low Temperature Versus Electrocautery Block Resection at High Frequency for Localized Recurrent Nasopharyngeal Carcinoma
NCT04425265Surgery, Recurrent Nasopharyngeal Carcinoma
Sun Yat-sen University
Not applicable
500
Guangzhou, Zhuhai, Nanchang
2020-06-30
Recruiting
A Multicenter, Phase 3, Randomized Trial of Sequencial Chemoradiotherapy with or Without Toripalimab (PD-1 Antibody) in Newly Diagnosed Early-Stage Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (ENKTL)
NCT04365036NK/T Cell Lymphoma Nos
Sun Yat-sen University
Phase 3
207
Guangzhou
2020-05-03
Recruiting
Detecting Chemosensitivity and Predicting Treatmemt Efficacy With CTCs in mNPC
NCT04544969Circulating Tumor Cell, Nasopharyngeal Carcinoma, Distant Metastases.Clinical, Effects of Chemotherapy
Sun Yat-sen University
Observational
50
Guangzhou
2020-04-01
Active, closed
Programmed Death-1 (PD-1) Antibody Combined With Chemoradiotherapy in High-risk Recurrent Nasopharyngeal Carcinoma
NCT03930498Recurrent Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2
68
Guangzhou
2020-03-12
Recruiting
PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma Patients
NCT03907826Recurrent Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3
212
Guangzhou, Beijing, Chengdu, Fuzhou, Guiyang, Hangzhou, Nanchang, Nanning
2020-03-01
Active, closed
Concurrent Chemoradiotherapy With Nimotuzumab for High Risk Nasopharyngeal Carcinoma
NCT04223024Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2
246
Guangzhou
2020-01-31
Recruiting
Analysis of Exploring Optimized Sequential Treatment Strategies of Antibody-Drug Conjugates (ADCs) in HER2-Low-Expressing Breast Cancer
NCT06877416Antibody-drug Conjugates, HER2-low Breast Cancer, Breast Neoplasms
Sun Yat-sen University
Observational
700
Guangzhou
2020-01-01
Recruiting
Concurrent Chemotherapy for Recurrent T3/T4 Nasopharyngeal Carcinoma
NCT04136886Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3
346
Guangzhou
2020-01-01
Active, closed
Pd1 Antibody Sintilimab ยฑ Chemoradiotherapy for Locally Advanced Rectal Cancer
NCT04304209Colorectal Cancer Stage II, Colorectal Cancer Stage III
Sun Yat-sen University
Phase 2
195
Guangzhou
2019-10-28
Active, closed
Sintilimab With P-GemOx Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-cell Lymphoma, Nasal Type
NCT04127227NK/T Cell Lymphoma Nos
Sun Yat-sen University
Phase 2
34
Guangzhou
2019-10-09
Recruiting
mFOLFIRINOX as Adjuvent Chemotherapy in Treating Chinese Pancreatic Cancer Patients
NCT04084496Pancreatic Cancer
Sun Yat-sen University
Phase 2
80
Guangzhou
2019-09-01
Active, closed
Myopic Optic Neuropathy in Chinese High Myopia Population
NCT04302220Eye Diseases
Sun Yat-sen University
Observational
813
Guangzhou
2019-06-06
Recruiting
Neoadjuvant Toripalimab With or Without Celecoxib in dMMR/MSI-H Colorectal Cancer
NCT03926338Colorectal Cancer, Mismatch Repair-deficient (dMMR), Microsatellite Instability-high (MSI-H), Neoadjuvant Therapy
Sun Yat-sen University
Phase 2
270
Guangzhou
2019-05-10
Active, closed
GP Vs PF As Induction Chemotherapy Combined with CCRT for Locoregionally Advanced Nasopharyngeal Carcinoma
NCT03840421Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Nasopharyngeal Diseases, Head and Neck Neoplasm
Sun Yat-sen University
Phase 3
468
Guangzhou
2019-04-03
Active, closed
HAIC Combined with PD-1 Inhibitor in Potentially Resectable Locally Advanced HCC
NCT03869034Hepatocellular Carcinoma
Sun Yat-sen University
Phase 2
40
Guangzhou
2019-03-25
Recruiting
Neoadjuvant IBI308, Bevacizumab, Plus Pemetrexed and Carboplatin Followed by Surgery in Unresectable Stage III NSCLC
NCT03872661Lung Cancer Stage III
Sun Yat-sen University
Phase 2
36
Guangzhou
2019-03-01
Active, closed
Study of Porcine Fibrin Sealant in Preventing Cervical Anastomotic Leakage (PLACE030)
NCT03847857Esophageal Anastomotic Leak
Sun Yat-sen University
Phase 3
360
Guangzhou, Jieyang, Shantou, Zhongshan, Chengdu, Shanghai
2019-02-21
Recruiting
Toripalimab๏ผˆJS001๏ผ‰ as Monotherapy in Participants With POLE or POLD-1 Mutated and Non-MSI-H Advanced Solid Tumors
NCT03810339Solid Tumor, Advanced Cancer
Sun Yat-sen University
Phase 2
35
Guangzhou, Guiyang, Wuhan, Dalian
2019-01-15
Active, closed
ACHP-THP vs EC-THP as Neoadjuvant Therapy for HER2-positive EBC
NCT04172259Breast Cancer, Neoadjuvant Chemotherapy
Sun Yat-sen University
Phase 2
156
Guangzhou
2019-01-10
Active, closed
TNT to Increase the Clinical Complete Response Rate for Distal LARC
NCT03840239Rectal Cancer, Rectal Cancer Stage II, Rectal Cancer Stage III, Chemoradiation
Sun Yat-sen University
Phase 2
98
Guangzhou
2018-12-25
Recruiting
Prospectively Randomized Control Clinical Trial of FOLFOXIRI Preoperative Chemotherapy Alone on Rectal Cancer in Local Advance Comparing to Oral Capecitabine Combined With Long-term Radiation
NCT03671252Rectal Cancer
Sun Yat-sen University
Phase 3
776
Guangzhou
2018-11-16
Recruiting
A Study of the Addition of Metronomic Capecitabine to Standard Adjuvant Therapy in High Risk HER2+ BC paTients
NCT03561740Breast Cancer
Sun Yat-sen University
Phase 3
794
Guangzhou
2018-07-25
Recruiting
Nanshan Elderly Cohort Study
NCT03569735Hypertension, Type 2 Diabetes Mellitus, Cardiovascular Diseases, Stroke
Sun Yat-sen University
Observational
20,000
Shenzhen, Guangzhou
2018-05-26
Active, closed
Cetuximab Plus FOLFOXIRI vs Cetuximab Plus FOLFOX For CRCLM
NCT03493048Colorectal Cancer, Liver Metastases
Sun Yat-sen University
Phase 2
146
Guangzhou
2018-04-15
Active, closed
TPF+CCRT vs.CCRT+PF in High Risk Nasopharyngeal Carcinoma
NCT03306121Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3
322
Guangzhou
2017-11-13
Recruiting
Endoscopic Nasopharyngectomy for Newly Diagnosed Stage I Nasopharyngeal Carcinoma Patients
NCT03353467Nasopharyngeal Carcinoma, Endoscopic Surgery, Primary Napharyngeal Carcinama, Stage I Nasopharyngeal Cancer
Sun Yat-sen University
Not applicable
228
Guangzhou, Zhongshan, Nanning
2017-10-01
Active, closed
Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
NCT03047265Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2
164
Guangzhou
2017-02-04
Recruiting
IgA Nephropathy Biomarkers Evaluation Study (INTEREST)
NCT02954419IgA Nephropathy, Glomerular Diseases
Sun Yat-sen University
Observational
2,000
Guangzhou
2016-11
Recruiting
Tricuspid RegurgitAtion rIsk modeL Study (TRAIL Study)
NCT06926959Tricuspid Regurgitation
Sun Yat-sen University
Observational
3,000
Guangzhou, Jieyang, Shantou, Shenzhen, Zhanjiang, Zhongshan
2016-06-15
Recruiting
MItral Regurgitation Risk Assessment and CLinical modElling
NCT06876883Mitral Insufficiency, Mitral Regurgitation (MR)
Sun Yat-sen University
Observational
2,000
Guangzhou
2016-06-15
Active, closed
Esthetic and Radiographic Outcomes Following Immediate Implant Placement With Thin or Dehiscence Buccal Bone Wall
NCT03319758Jaw, Edentulous, Partially, Acquired Absence of Single Tooth
Sun Yat-sen University
Not applicable
15
Guangzhou
2016-05
Recruiting
Esthetic, Clinical and Radiographic Outcomes of Immediate and Delayed Implant Placement
NCT02814149Jaw, Edentulous, Partially, Acquired Absence of Single Tooth
Sun Yat-sen University
Not applicable
40
Guangzhou
2016-05
Recruiting
Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer
NCT02966483Rectal Neoplasms Malignant, Surgery
Sun Yat-sen University
Not applicable
1,114
Beijing, Chongqing, Guangzhou, Zhanjiang, Zunyi, Changsha, Hengyang, Changchun
2016-04
Recruiting
Super Chinese Nephrotic Syndrome Registration System (SUCCESS)
NCT03001934Nephrotic Syndrome
Sun Yat-sen University
Observational
5,000
Guangzhou
2016-04
Recruiting
The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) Who Underwent Hepatectomy : A Random, Controlled, Stage III Clinical Trial.
NCT03368651Hepatocellular Carcinoma
Sun Yat-sen University
Phase 3
230
Guangzhou
2016-01-01
Active, closed
Sentinel Lymph Node Biopsy Versus Pelvic Lymphadenectomy in Early-stage Cervical Cancer (PHENIX/CSEM 010)
NCT02642471Cervical Cancer, Surgery, Quality of Life
Sun Yat-sen University
Not applicable
1,080
Guangzhou
2015-12-31
Active, closed
The Role of Induction Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of IMRT
NCT02460887Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3
236
Guangzhou
2015-06
Active, closed
FOLFOX or CAPOX Perioperative Chemotherapy Versus Postoperative Chemotherapy for Locally Advanced Colon Cancer (OPTICAL)
NCT02572141Colon Cancer
Sun Yat-sen University
Phase 3
738
Guangzhou
2015-01-01
Recruiting
REal-world Data of CARdiometabolic ProtEcTion
NCT07038083Cardiometabolic Diseases
Sun Yat-sen University
Observational
40,000
Guangzhou
2014-01-01
Recruiting
Peritoneal Dialysis Registration System (PERSIST)
NCT02989298ESRD, Disorders Associated With Peritoneal Dialysis
Sun Yat-sen University
Observational
10,000
Guangzhou
2013-12
Recruiting
Wise Practice of Chinese Hemodialysis (WISHES)
NCT03001921Haemolyses and Related Conditions
Sun Yat-sen University
Observational
30,000
Guangzhou
2013-12
Recruiting
High Quality Evidence of Chinese Lupus Nephritis (HELP)
NCT03001973Lupus Nephritis
Sun Yat-sen University
Observational
5,000
Guangzhou
2013-11
Recruiting
Causation And Prognosis Analyses of Coronary Artery Diseases: A Longitudinal Cohort Study
NCT07480512Coronary Artery Disease
Sun Yat-sen University
Observational
30,000
Guangzhou
2013-01-01
Recruiting
Myocardial Protection Effect of Simvastatin Undergoing Cardiac Surgery
NCT01653223Congenital Heart Disease, Heart Valve Disease
Sun Yat-sen University
Not applicable
369
Guangzhou
2013-01
Recruiting
IgA Nephropathy Registration Initiative of High Quality (INSIGHT)
NCT03001947IgA Nephropathy
Sun Yat-sen University
Observational
10,000
Guangzhou
2012-11
Recruiting
A Retrospective Study of EGFR-TKIs,Gefitinib, Erlotinib and Osimertinib in NSCLC Patients Treatment
NCT01994057Non-small Cell Lung Cancer (NSCLC), EGFR-TKI Resistant Mutation, EGFR-TKI Sensitizing Mutation, Germline Mutations
Sun Yat-sen University
Observational
1,000
Guangzhou
2012-09
Recruiting
A Study of 2nd-line FOLFIRI ยฑ Bevacizumab vs. Irinotecan ยฑ Bevacizumab in mCRC
NCT03303495Colorectal Neoplasms, Neoplasm Metastasis, Intestinal Neoplasms, Gastrointestinal Neoplasms
Sun Yat-sen University
Phase 3
280
Guangzhou
2011-11-14
Recruiting
The New Serial Treatment of Temporomandibular Disorders
NCT00932594Temporomandibular Disorder
Sun Yat-sen University
Not applicable
4
Guangzhou
2006-01
Recruiting
The Chinese Pulmonary Lymphoepithelioma-like Carcinoma Collaboration Study
NCT06801977Primary Pulmonary Lymphoepithelioma-like Carcinoma
Sun Yat-sen University
Observational
10,000
Foshan, Guangzhou
2002-01-01
Rows per page Showing 401–451 of 451
Previous 3 4 5
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china/city/guangzhou?page=5

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.